Literature DB >> 15176694

Functional residual capacity measurements in healthy infants: ultrasonic flow meter versus a mass spectrometer.

J J Pillow1, H Ljungberg, G Hülskamp, J Stocks.   

Abstract

Accurate, reproducible and portable bedside monitoring of lung volume could potentially facilitate the early recognition of both under and overinflation of the lungs in ventilated and nonventilated subjects. This study asked whether a prototype portable ultrasonic flow meter provided valid and reliable measurements of functional residual capacity (FRCUS) when compared to those obtained using a mass spectrometer (FRCMS) in nonventilated healthy infants. Paired, randomised measurements of FRCMS and FRCUS were obtained using the sulphur hexafluoride (SF6) multiple-breath washout technique in 23 healthy infants with a median (range) postnatal age of 34.6 (1.3-92.6) weeks and weight of 8.3 (3.9-11.7) kg. FRCUS was on average 5.7%, (95% CI: 1.0-10.4%) less than FRCMS equating to a difference of approximately 1 mL x kg(-1). The 95% limits of agreement (LA) between the two techniques were relatively wide (95% LA: -17.5% to 29%), although in keeping with previously reported within-patient variability for lung volume measurements. There was no significant difference between the within subject coefficient of variation for FRCMS (3.7%) and FRCUS (5.2%). The ultrasonic flow meter used in this study provides repeatable measurements of functional residual capacity in spontaneously breathing healthy infants that approximate those obtained during mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176694     DOI: 10.1183/09031936.04.00091504

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Ventilation homogeneity improves with growth early in life.

Authors:  Valentina C Chakr; Conrado J Llapur; Edgar E Sarria; Rita Mattiello; Jeffrey Kisling; Christina Tiller; Risa Kimmel; Brenda Poindexter; Robert S Tepper
Journal:  Pediatr Pulmonol       Date:  2011-09-07

2.  A realistic validation study of a new nitrogen multiple-breath washout system.

Authors:  Florian Singer; Birgitta Houltz; Philipp Latzin; Paul Robinson; Per Gustafsson
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  Tidal volume single breath washout of two tracer gases--a practical and promising lung function test.

Authors:  Florian Singer; Georgette Stern; Cindy Thamrin; Oliver Fuchs; Thomas Riedel; Per Gustafsson; Urs Frey; Philipp Latzin
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

4.  Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening.

Authors:  Graham L Hall; Karla M Logie; Faith Parsons; Sven M Schulzke; Gary Nolan; Conor Murray; Sarath Ranganathan; Phil Robinson; Peter D Sly; Stephen M Stick; Luke Berry; Luke Garratt; John Massie; Lauren Mott; Srinivas Poreddy; Shannon Simpson
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

5.  Impact of Software Settings on Multiple-Breath Washout Outcomes.

Authors:  Selina Summermatter; Florian Singer; Philipp Latzin; Sophie Yammine
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

6.  Lung volume assessments in normal and surfactant depleted lungs: agreement between bedside techniques and CT imaging.

Authors:  Gergely Albu; Ferenc Petak; Tristan Zand; Magnus Hallbäck; Mats Wallin; Walid Habre
Journal:  BMC Anesthesiol       Date:  2014-08-05       Impact factor: 2.217

7.  In vitro and in vivo functional residual capacity comparisons between multiple-breath nitrogen washout devices.

Authors:  Katrina O Tonga; Paul D Robinson; Claude S Farah; Greg G King; Cindy Thamrin
Journal:  ERJ Open Res       Date:  2017-10-02

8.  Multiple breath nitrogen washout: a feasible alternative to mass spectrometry.

Authors:  Renee Jensen; Sanja Stanojevic; Karyn Gibney; Juliana Giraldo Salazar; Per Gustafsson; Padmaja Subbarao; Felix Ratjen
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.